Berman Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-524
| Closed | -$95K | – | 2319 |
|
|
2021
Q2 | $95K | Buy |
524
+120
| +30% | +$21.8K | 0.02% | 399 |
|
|
2021
Q1 | $61K | Buy |
404
+180
| +80% | +$27.2K | 0.01% | 416 |
|
|
2020
Q4 | $34K | Buy |
224
+15
| +7% | +$2.28K | 0.01% | 516 |
|
|
2020
Q3 | $23K | Buy |
209
+97
| +87% | +$10.7K | 0.01% | 545 |
|
|
2020
Q2 | $12K | Buy |
112
+7
| +7% | +$750 | ﹤0.01% | 707 |
|
|
2020
Q1 | $9K | Sell |
105
-37
| -26% | -$3.17K | ﹤0.01% | 712 |
|
|
2019
Q4 | $15K | Buy |
142
+53
| +60% | +$5.6K | ﹤0.01% | 628 |
|
|
2019
Q3 | $8K | Sell |
89
-84
| -49% | -$7.55K | ﹤0.01% | 814 |
|
|
2019
Q2 | $22K | Sell |
173
-149
| -46% | -$18.9K | 0.01% | 493 |
|
|
2019
Q1 | $42K | Buy |
322
+131
| +69% | +$17.1K | 0.01% | 305 |
|
|
2018
Q4 | $18K | Buy |
+191
| New | +$18K | 0.01% | 406 |
|